My Cart
You have no items in your shopping cart.
Ship in Europe, Find out rates!
Language
Enterogermina 10 Bottles 4 Billion 5ml
Regular Price
€16.90
Special Price
€12.02
-29%
Save: €4.88
In stock
Recent lowest price:
€12.02
- box Delivery in Italy in 24/48 and free returns
- star3.000+ positive reviews
- dropboxOver 60,000 products in the catalog
Manufacturer
SANOFI
SKU
013046077
Active principle
BACILLUS CLAUSII
NAME
ENTEROGERMINA 4 BILLION / 5 ML ORAL SUSPENSION
PHARMACOTHERAPEUTIC CATEGORY
Antidiarrheal microorganisms.
ACTIVE PRINCIPLES
One vial contains: 4 billion resistant polyantibiotic Bacillus clausii spores.
EXCIPIENTS
Purified water.
INDICATIONS
Treatment and prophylaxis of intestinal dysmicrobism and consequent endogenous vitaminosis. Adjuvant therapy for the restoration of intestinal microbial flora, altered during antibiotic or chemotherapy treatments. Acute and chronic gastro-enteric disorders of infants, attributable to intoxication or intestinal dysmicrobism and disvitaminosis.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients.
DOSAGE
Adults: 1 vial per day. Infants and children: 1 vial per day. Take the contents of the vial as it is or by diluting in water or other drinks (eg milk, tea, orange juice). This medicine is for oral use only. Do not inject or administer in any other way.
STORAGE
Store below 30 degrees C.
WARNINGS
The possible presence of visible corpuscles in the vials of the drug is due to aggregates of Bacillus clausii spores; therefore it is not an altered product index. Shake the vial before use. This medicine is for oral use only. Do not inject or administer by any other route. Incorrect use of the medicinal product has resulted in severe anaphylactic reactions such as anaphylactic shock. In the course of antibiotic therapy it is recommended to administer the preparation in the interval between one and the other antibiotic administration.
INTERACTIONS
No interaction studies have been performed.
SIDE EFFECTS
Skin and subcutaneous tissue disorders. Not known: hypersensitivity reactions', including rash, urticaria and angioedema. Report any suspected adverse reactions via the national reporting system.
PREGNANCY AND BREASTFEEDING
There are no foreclosures from the use of the preparation during pregnancy or during breastfeeding.
ENTEROGERMINA 4 BILLION / 5 ML ORAL SUSPENSION
PHARMACOTHERAPEUTIC CATEGORY
Antidiarrheal microorganisms.
ACTIVE PRINCIPLES
One vial contains: 4 billion resistant polyantibiotic Bacillus clausii spores.
EXCIPIENTS
Purified water.
INDICATIONS
Treatment and prophylaxis of intestinal dysmicrobism and consequent endogenous vitaminosis. Adjuvant therapy for the restoration of intestinal microbial flora, altered during antibiotic or chemotherapy treatments. Acute and chronic gastro-enteric disorders of infants, attributable to intoxication or intestinal dysmicrobism and disvitaminosis.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients.
DOSAGE
Adults: 1 vial per day. Infants and children: 1 vial per day. Take the contents of the vial as it is or by diluting in water or other drinks (eg milk, tea, orange juice). This medicine is for oral use only. Do not inject or administer in any other way.
STORAGE
Store below 30 degrees C.
WARNINGS
The possible presence of visible corpuscles in the vials of the drug is due to aggregates of Bacillus clausii spores; therefore it is not an altered product index. Shake the vial before use. This medicine is for oral use only. Do not inject or administer by any other route. Incorrect use of the medicinal product has resulted in severe anaphylactic reactions such as anaphylactic shock. In the course of antibiotic therapy it is recommended to administer the preparation in the interval between one and the other antibiotic administration.
INTERACTIONS
No interaction studies have been performed.
SIDE EFFECTS
Skin and subcutaneous tissue disorders. Not known: hypersensitivity reactions', including rash, urticaria and angioedema. Report any suspected adverse reactions via the national reporting system.
PREGNANCY AND BREASTFEEDING
There are no foreclosures from the use of the preparation during pregnancy or during breastfeeding.